"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Descriptor ID |
D006490
|
MeSH Number(s) |
D27.505.954.502.270.463
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in this website by year, and whether "Hemostatics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2011 | 2 | 0 | 2 |
2013 | 2 | 1 | 3 |
2016 | 0 | 2 | 2 |
2017 | 0 | 2 | 2 |
2018 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma. Anesth Analg. 2023 05 01; 136(5):894-904.
-
Viscoelastic Hemostatic Assays-Training the Next Canary for Hemostatic Resuscitation in Trauma. Anesth Analg. 2022 06 01; 134(6):e41-e42.
-
Perioperative Management of Hereditary Factor V Deficiency: Timing of Plasma Administration is Critical in Maximizing Hemostatic Potency of Transfused Factor V. J Cardiothorac Vasc Anesth. 2022 06; 36(6):1811-1812.
-
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Haemophilia. 2021 Nov; 27(6):911-920.
-
Fibrinogen Concentrate: Is It Standard Currency or Bitcoin in Bleeding Management? Anesth Analg. 2018 09; 127(3):603-604.
-
Reduced Requirement for Prothrombin Complex Concentrate for the Restoration of Thrombin Generation in Plasma From Liver Transplant Recipients. Anesth Analg. 2017 08; 125(2):609-615.
-
Reassessing RECESS: In Pursuit of the Golden Ratio of Hemostatic Components to Red Blood Cells. Anesth Analg. 2017 06; 124(6):1760-1761.
-
Practical Use of Thromboelastometry in the Management of Perioperative Coagulopathy and Bleeding. Transfus Med Rev. 2017 01; 31(1):11-25.
-
Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation. Ann Card Anaesth. 2016 Jul-Sep; 19(3):418-24.
-
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia. 2014 Mar; 20(2):158-67.